Federal contractor · CHARLOTTE, NC

ONCOTAB, INC.

No contract obligations recorded for ONCOTAB, INC. in FY2026. Since FY2017: $0. It also received $1.1M in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
E5FXNY7GG5M5
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 0FY2017
  2. 0FY2018

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for ONCOTAB, INC. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

ONCOTAB, INC. received $1.1M in federal assistance in FY2026, on 2 actions (1 new awards), +183% vs FY2025. Its largest program was 93.395 · Cancer Treatment Research ($1.1M).

Assistance · FY2026
$1.1M
New awards
1
Actions
2
Since FY2021
$2.2M

Assistance by fiscal year

  1. 660.6KFY2021
  2. 0FY2024
  3. 400KFY2025
  4. 1.1MFY2026

By type

  1. Grants$1.1M100%

Top programs

  1. 93.395 · Cancer Treatment Research$1.1M100%

Awarding agencies

  1. National Institutes of Health$1.1M100%
    Department of Health and Human Services

Largest awards

  1. COMBINATION THERAPY OF T-CELL ENGAGER AND CHEMOTHERAPY FOR PANCREATIC CANCER TREATMENT - THE AMERICAN CANCER SOCIETY ESTIMATES THAT IN 2025…$1.1M
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Jul 17, 2026 – Jul 17, 2026· R44CA306447
  2. OPTIMIZED TARGETED RADIOTHERAPY OF PANCREATIC CANCER - ABSTRACT PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) HAS A 5-YEAR SURVIVAL RATE OF LESS…$400K
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· May 22, 2025 – Apr 13, 2026· R41CA284997

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2021–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026.